Nathani, A.; Sun, L.; Khan, I.; Aare, M.; Bagde, A.; Li, Y.; Singh, M.
Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations. Pharmaceutics 2024, 16, 83.
https://doi.org/10.3390/pharmaceutics16010083
AMA Style
Nathani A, Sun L, Khan I, Aare M, Bagde A, Li Y, Singh M.
Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations. Pharmaceutics. 2024; 16(1):83.
https://doi.org/10.3390/pharmaceutics16010083
Chicago/Turabian Style
Nathani, Aakash, Li Sun, Islauddin Khan, Mounika Aare, Arvind Bagde, Yan Li, and Mandip Singh.
2024. "Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations" Pharmaceutics 16, no. 1: 83.
https://doi.org/10.3390/pharmaceutics16010083
APA Style
Nathani, A., Sun, L., Khan, I., Aare, M., Bagde, A., Li, Y., & Singh, M.
(2024). Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations. Pharmaceutics, 16(1), 83.
https://doi.org/10.3390/pharmaceutics16010083